These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 19061136)
21. A compilation of microdosimetry for uniformly distributed Auger emitters used in medicine. Chen J Int J Radiat Biol; 2008 Dec; 84(12):1027-33. PubMed ID: 19061126 [TBL] [Abstract][Full Text] [Related]
22. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer. Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464 [TBL] [Abstract][Full Text] [Related]
23. The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells. Yde CW; Clausen MP; Bennetzen MV; Lykkesfeldt AE; Mouritsen OG; Guerra B Anticancer Drugs; 2009 Sep; 20(8):723-35. PubMed ID: 19584708 [TBL] [Abstract][Full Text] [Related]
24. Radioiodinated ligands for the estrogen receptor: effect of different 7-cyanoalkyl chains on the binding affinity of novel iodovinyl-6-dehydroestradiols. Neto C; Oliveira MC; Gano L; Marques F; Santos I; Morais GR; Yasuda T; Thiemann T; Botelho F; Oliveira CF Appl Radiat Isot; 2009 Feb; 67(2):301-7. PubMed ID: 19049850 [TBL] [Abstract][Full Text] [Related]
25. Bromine-80m-labeled estrogens: Auger electron-emitting, estrogen receptor-directed ligands with potential for therapy of estrogen receptor-positive cancers. DeSombre ER; Mease RC; Hughes A; Harper PV; DeJesus OT; Friedman AM Cancer Res; 1988 Feb; 48(4):899-906. PubMed ID: 3338083 [TBL] [Abstract][Full Text] [Related]
26. Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism. Girón RA; Montaño LF; Escobar ML; López-Marure R FEBS J; 2009 Oct; 276(19):5598-609. PubMed ID: 19702826 [TBL] [Abstract][Full Text] [Related]
28. Control of cell death (apoptosis) by diethylstilbestrol in an estrogen-dependent kidney tumor. Bursch W; Liehr JG; Sirbasku DA; Putz B; Taper H; Schulte-Hermann R Carcinogenesis; 1991 May; 12(5):855-60. PubMed ID: 2029749 [TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase inhibitor induced modulation of anti-estrogen therapy. Thomas S; Munster PN Cancer Lett; 2009 Aug; 280(2):184-91. PubMed ID: 19185986 [TBL] [Abstract][Full Text] [Related]
30. Hydroperoxidative oxidation of diethylstilbestrol by lipoxygenase. Núñez-Delicado E; Sánchez-Ferrer A; García-Carmona F Arch Biochem Biophys; 1997 Dec; 348(2):411-4. PubMed ID: 9434755 [TBL] [Abstract][Full Text] [Related]
31. Preparation and in vitro evaluation of radioiodinated bakuchiol as an anti tumor agent. Bapat K; Chintalwar GJ; Pandey U; Thakur VS; Sarma HD; Samuel G; Pillai MR; Chattopadhyay S; Venkatesh M Appl Radiat Isot; 2005 Mar; 62(3):389-93. PubMed ID: 15607914 [TBL] [Abstract][Full Text] [Related]
32. Effects of neonatally administered high-dose diethylstilbestrol on the induction of mammary tumors induced by 7,12-dimethylbenz[a]anthracene in female rats. Kawaguchi H; Umekita Y; Souda M; Gejima K; Kawashima H; Yoshikawa T; Yoshida H Vet Pathol; 2009 Jan; 46(1):142-50. PubMed ID: 19112128 [TBL] [Abstract][Full Text] [Related]
33. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells. Gionet N; Jansson D; Mader S; Pratt MA J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539 [TBL] [Abstract][Full Text] [Related]
34. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells. Girgert R; Hanf V; Emons G; Gründker C J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736 [TBL] [Abstract][Full Text] [Related]
35. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway. Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281 [TBL] [Abstract][Full Text] [Related]
36. Effects of diethylstilbestrol on ovarian follicle development in neonatal mice. Kim H; Hayashi S; Chambon P; Watanabe H; Iguchi T; Sato T Reprod Toxicol; 2009 Jan; 27(1):55-62. PubMed ID: 19027844 [TBL] [Abstract][Full Text] [Related]
37. DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. Hartmann O; Spyratos F; Harbeck N; Dietrich D; Fassbender A; Schmitt M; Eppenberger-Castori S; Vuaroqueaux V; Lerebours F; Welzel K; Maier S; Plum A; Niemann S; Foekens JA; Lesche R; Martens JW Clin Cancer Res; 2009 Jan; 15(1):315-23. PubMed ID: 19118060 [TBL] [Abstract][Full Text] [Related]
38. Endobronchial clear cell adenocarcinoma occurring in a patient 15 years after treatment for DES-associated vaginal clear cell adenocarcinoma. Hall WB; Detterbeck FC; Livasy CA; Fowler WC Gynecol Oncol; 2004 Jun; 93(3):708-10. PubMed ID: 15196869 [TBL] [Abstract][Full Text] [Related]
39. Rapid simultaneous determination of apoptosis, necrosis, and viability in sulfur mustard exposed HaCaT cell cultures. Heinrich A; Balszuweit F; Thiermann H; Kehe K Toxicol Lett; 2009 Dec; 191(2-3):260-7. PubMed ID: 19766703 [TBL] [Abstract][Full Text] [Related]
40. Biological evaluation of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone as an anti-breast cancer agent. Kanaan YM; Das JR; Bakare O; Enwerem NM; Berhe S; Beyene D; Williams V; Zhou Y; Copeland RL Anticancer Res; 2009 Jan; 29(1):191-9. PubMed ID: 19331150 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]